-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Coeptis Therapeutics Holdings, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2022 to Q2 2024.
- Coeptis Therapeutics Holdings, Inc. Interest Expense for the quarter ending June 30, 2024 was $66.1K, a 54.9% increase year-over-year.
- Coeptis Therapeutics Holdings, Inc. Interest Expense for the twelve months ending June 30, 2024 was $300K, a 73.7% increase year-over-year.
- Coeptis Therapeutics Holdings, Inc. annual Interest Expense for 2023 was $108K, a 50.7% decline from 2022.
- Coeptis Therapeutics Holdings, Inc. annual Interest Expense for 2022 was $218K, a 16.7% increase from 2021.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)